comparemela.com

Latest Breaking News On - Human research ethics - Page 2 : comparemela.com

Australia plans to regulate high-risk AI Here s how to do that successfully

While regulating some AI applications is a step in the right direction, Australians would be better off with more ongoing expert advice and more regulation.

Australia plans to regulate high-risk AI Here s how to do that successfully

Australia plans to regulate high-risk AI Here s how to do that successfully
techxplore.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techxplore.com Daily Mail and Mail on Sunday newspapers.

Incidence and Cost of Potentially Avoidable Emergency Department Visits for Urolithiasis

This study characterizes the incidence and associated factors of urolithiasis-related emergency department visits that are potentially preventable with appropriate ambulatory care and calculates their cumulative costs.

The Clinical Promise and Ethical Pitfalls of Electronic Phenotyping

The Clinical Promise and Ethical Pitfalls of Electronic Phenotyping
healthitanalytics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthitanalytics.com Daily Mail and Mail on Sunday newspapers.

Safer medicines To reduce falls and refractures for OsteoPorosis (#STO by Rebekah Jane Moles, Lin Perry et al

INTRODUCTION: Minimal trauma fractures (MTFs) often occur in older patients with osteoporosis and may be precipitated by falls risk-increasing drugs. One category of falls risk-increasing drugs of concern are those with sedative/anticholinergic properties. Collaborative medication management services such as Australia's Home Medicine Review (HMR) can reduce patients' intake of sedative/anticholinergics and improve continuity of care. This paper describes a protocol for an randomised controlled trial to determine the efficacy of an HMR service for patients who have sustained MTF. METHOD AND ANALYSIS: Eligible participants are as follows: ≥65 years of age, using ≥5 medicines including at least one falls risk-increasing drug, who have sustained an MTF and under treatment in one of eight Osteoporosis Refracture Prevention clinics in Australia. Consenting participants will be randomised to control (standard care) or intervention groups. For the intervention group, medical spec

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.